On 5 March 2019, the US Food and Drug Administration (FDA) approved the nasal spray medication Spravato (esketamine) for treatment-resistant depression in adults. Some people are applauding this new medication as a much-needed shift from the era of antidepressants, including Prozac, Zoloft, and Paxil. “Finally, a drug that uses a different mechanism of action than these older antidepressants,” they cheer. Esketamine is a glutamate receptor modulator that is believed to help restore synaptic connections in a depressed person’s brain cells. Other critics are more skeptical, concerned it won’t be the panacea we’ve been looking for.
Deployment Psychology Blog
The percentage of Service members who participated in a Military Times survey last fall who reported having seen "signs of white nationalism or racist ideology within the armed forces," according to a recent Military Times article, White nationalism remains a problem for the military, poll suggests. "Among non-white service members in the poll, incidents of racism and racist ideology increased from 42 percent in 2017 to more than half those surveyed in 2018."
Welcome to this week’s edition of CDP News! We like to use this space to review recent happenings in and around the Center for Deployment Psychology, while also looking ahead to upcoming events. We're saying good-bye to March and welcoming in April and several new events.
The weekly Research Update contains the latest news, journal articles, useful links from around the web. Some of this week's topics include:
● Military psychologists and cultural competence: exploring implications for the manifestation and treatment of psychological trauma in the British armed forces.
● From the therapeutic to the post-therapeutic: The resilient subject, its social imaginary, and its practices in the shadow of 9/11.
● The role of community context and psychological well-being for physical health: A dyadic study of military couples.
CDP, together with National Center for PTSD, recently completed the first of three training events in Prolonged Exposure (PE) with community providers who treat Veterans with PTSD as part of a pilot project funded by the National Center for PTSD. We interviewed Dr. Sonya Norman, director of the VA’s PTSD Consultation Program and Mr. Todd McKee, program manager, who are leading this project.